Upstate Active Clinical Trials

Study Title:

SWOG S0931 EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study

What is the purpose of the study?

This phase III trial is studying everolimus to see how well it works in treating patients with kidney cancer who have undergone surgery.

Upstate Institutional Review Board (IRB) Number:

408915

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Sam Benjamin, MD

ClinicalTrials.Gov ID:

NCT01120249

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Diane M Gould
Phone: 315-464-8235
Email: gouldd@upstate.edu

Return to Previous Page || Search Again